Advancing Virtual Reality-Based Attentional Bias as a Biomarker for Tobacco Use Disorder, San Diego, California, 2024-2025
收藏DataCite Commons2026-04-13 更新2026-05-03 收录
下载链接：
https://www.icpsr.umich.edu/web/NAHDAP/studies/39816
下载链接
链接失效反馈官方服务：
资源简介：
The Varenicline Virtual Reality Study includes daily cigarette users, ages 22+, from the San Diego community. Participants are assessed on the VR Nicotine Cue Exposure paradigm then pseudo-randomized (stratified on age and sex) to receive varenicline (target dose 1mg twice daily) or placebo (target n per group=100; target total N=200). Following eight days of titration, participants are assessed again on the VR Nicotine Cue Exposure paradigm.
提供机构：
ICPSR - Interuniversity Consortium for Political and Social Research
创建时间：
2026-04-13
